官方服务：
资源简介：
Using Liraglutide for obesity management
应用场景：
创建时间：
2021-07-02
相关数据集
Data Matrix and Differential metabolites-TISSUE.xlsx
These were the metabonomics data from KPC mice which were divided into 8 groups and administered with the following regimens: PBS, mTOR inhibitor sirolimus, PD-L1 antibody, gemcitabine, sirolimus + PD
DataCite Commons2022-11-06 更新120
The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study
Background : Volanesorsen, an investigational inhibitor of apoC-III synthesis, significantly reduced triglyceride levels in clinical trials in patients with familial chylomicronemia syndrome (FC
DataCite Commons2020-08-29 更新110
schoenle_medication_data.xlsx
Schoenle et al. 2017. An experimental test of the physiological consequences of avian malaria infection. Journal of Animal Ecology. DOI:10.1111/1365-2656.12753
DataCite Commons2020-09-02 更新40
Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
The syndrome of inappropriate antidiuresis (SIAD) is the main cause of hyponatremia and the SGLT2-inhibitor empagliflozin is a promising new treatment option. A biomarker predicting treatment response
DataCite Commons2021-10-11 更新110
COX-2 EXPRESSION TREATMENT GROUP 3rd DAY
COX-2 EXPRESSION TREATMENT GROUP 3rd DAY
DataCite Commons2022-03-17 更新70
